Outcome of Programmable Lumboperitoneal Shunt in the Surgical Management of Idiopathic Normal Pressure Hydrocephalus

Wameedh Abdul Hussein; Mohammed Thakir Alkubaisi

doi:10.54133/ajms.v7i2.1515

Authors

Wameedh Abdul Hussein Department of Surgery, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0009-0003-7629-7672
Mohammed Thakir Alkubaisi Department of Surgery, Faculty of Medicine, University of Ibn Sina for Medical Sciences, Baghdad, Iraq https://orcid.org/0009-0000-1102-6079

DOI:

https://doi.org/10.54133/ajms.v7i2.1515

Keywords:

Lumboperitoneal shunt, Normal pressure hydrocephalus, Programmable LP shunt

Abstract

Background: Normal pressure hydrocephalus (NPH) is a complex neurological disorder characterized by enlarged ventricles in the brain. While the ventriculoperitoneal shunt is the preferred procedure, lumbar-peritoneal shunts also serve as an alternative. Lumbo-peritoneal shunts are an alternative for diverting cerebrospinal fluid without intracranial surgery. Objectives: To assess the efficacy of programmable LP shunts in managing idiopathic normal-pressure hydrocephalus (iNPH), focusing on postoperative outcomes and complications. Methods: This is a multicenter cohort study, including retrospective and prospective data. It involves 20 iNPH hospitalized patients from January 1st, 2019, to January 1st, 2022. The patients underwent programmable lumboperitoneal shunt surgery and had a six-month follow-up period. Patients with confirmed diagnosis of iNPH were included in this study. Other possible causes of symptoms were ruled out, and there were no reasons why the LP shunt should not be placed. Results: This cohort study involved 20 iNPH patients treated with programmable LP shunts; 19 patients (95%) experienced gait improvement, 16(80%) showed improvement in urinary symptoms, and 16 patients (80%) showed improvement in dementia. The most common post-operative complications included over-shunting (15%), subdural hygroma, CSF collection, and infection (10%). Most patients presented between 2–4 months. When evaluating predictors of operative time, the regression analysis revealed no significant factor that could predict operative time accurately. Conclusions: Lumbar-peritoneal shunts showed significant effectiveness rates with a moderate complication rate. It is minimally invasive without life-threatening complications and can be recommended for iNPH treatment.

Downloads

Download data is not yet available.

References

Passos-Neto CEB, Lopes CCB, Teixeira MS, Studart Neto A, Spera RR. Normal pressure hydrocephalus: an update. Arq Neuropsiquiatr. 2022;80(5 Suppl 1):42-52. doi: 10.1590/0004-282X-ANP-2022-S118.

Greenberg MS, Arredondo N, (Eds.), Handbook of neurosurgery: Thieme New York; 2001.

Oliveira LM, Nitrini R, Román GC. Normal-pressure hydrocephalus: A critical review. Dement Neuropsychol. 2019;13(2):133-143. doi: 10.1590/1980-57642018dn13-020001.

Pyykkö OT, Nerg O, Niskasaari HM, Niskasaari T, Koivisto AM, Hiltunen M, et al. Incidence, comorbidities, and mortality in idiopathic normal pressure hydrocephalus. World Neurosurg. 2018;112:e624-e631. doi: 10.1016/j.wneu.2018.01.107.

Trungu S, Scollato A, Ricciardi L, Forcato S, Polli FM, Miscusi M, et al. Clinical outcomes of shunting in normal pressure hydrocephalus: A multicenter prospective observational study. J Clin Med. 2022;11(5):1286. doi: 10.3390/jcm11051286. PMID: 35268376; PMCID: PMC8911143.

Nadkarni TD, Rekate HL, Wallace D. Concurrent use of a lumboperitoneal shunt with programmable valve and ventricular access device in the treatment of pseudotumor cerebri: review of 40 cases. J Neurosurg Pediatr. 2008;2(1):19-24. doi: 10.3171/PED/2008/2/7/019.

Toma AK, Tarnaris A, Kitchen ND, Watkins LD. Use of the proGAV shunt valve in normal-pressure hydrocephalus. Neurosurgery. 2011;68(2 Suppl Operative):245-249. doi: 10.1227/NEU.0b013e318214a809.

Lemcke J, Meier U. Improved outcome in shunted iNPH with a combination of a Codman Hakim programmable valve and an Aesculap-Miethke Shunt Assistant. Cent Eur Neurosurg. 2010;71(3):113-116. doi: 10.1055/s-0029-1241179.

Kiefer M, Eymann R, Komenda Y, Steudel WI. A grading system for chronic hydrocephalus. Zentralbl Neurochir. 2003;64(3):109-115. doi: 10.1055/s-2003-41881.

Serarslan Y, Yilmaz A, Çakır M, Güzel E, Akakin A, Güzel A, et al. Use of programmable versus nonprogrammable shunts in the management of normal pressure hydrocephalus: A multicenter retrospective study with cost-benefit analysis in Turkey. Medicine (Baltimore). 2017;96(39):e8185. doi: 10.1097/MD.0000000000008185.

Thavarajasingam SG, El-Khatib M, Rea M, Russo S, Lemcke J, Al-Nusair L, et al. Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir (Wien). 2021;163(10):2641-2672. doi: 10.1007/s00701-021-04922-z.

Nakajima M, Yamada S, Miyajima M, Ishii K, Kuriyama N, Kazui H, et al. Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo). 2021;61(2):63-97. doi: 10.2176/nmc.st.2020-0292.

Miyake H. Shunt devices for the treatment of adult hydrocephalus: Recent progress and characteristics. Neurol Med Chir (Tokyo). 2016;56(5):274-83. doi: 10.2176/nmc.ra.2015-0282.

Toma AK, Dherijha M, Kitchen ND, Watkins LD. Use of lumboperitoneal shunts with the Strata NSC valve: a single-center experience. J Neurosurg. 2010;113(6):1304-1308. doi: 10.3171/2010.6.JNS1020.

Bloch O, McDermott MW. Lumboperitoneal shunts for the treatment of normal pressure hydrocephalus. J Clin Neurosci. 2012;19(8):1107-1111. doi: 10.1016/j.jocn.2011.11.019.

Bayar MA, Tekiner A, Celik H, Yilmaz A, Menekse G, Yildirim T, et al. Efficacy of lumboperitoneal shunting in patients with normal pressure hydrocephalus. Turk Neurosurg. 2018;28(1):62-66. doi: 10.5137/1019-5149.JTN.18702-16.1.